150 related articles for article (PubMed ID: 4966488)
1. Thio-TEPA and methotrexate chemotherapy of advanced ovarian carcinoma.
Greenspan EM
J Mt Sinai Hosp N Y; 1968; 35(1):52-67. PubMed ID: 4966488
[No Abstract] [Full Text] [Related]
2. Comparison of regression induction with triethylenethiophosphoramide or methotrexate in bulky stage IIIb ovarian carcinoma.
Greenspan EM; Bruckner HW
Natl Cancer Inst Monogr; 1975 Oct; 42():173-5. PubMed ID: 825779
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
Wu BZ
Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
[No Abstract] [Full Text] [Related]
4. Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.
Wallach RC; Kabakow B; Blinick G; Antopol W
Obstet Gynecol; 1970 Feb; 35(2):278-86. PubMed ID: 4189962
[No Abstract] [Full Text] [Related]
5. Chemotherapy in the treatment of ovarian cancer.
Limburg HG
Proc R Soc Med; 1969 Apr; 62(4):361-2. PubMed ID: 4980488
[No Abstract] [Full Text] [Related]
6. Treatment of advanced inoperable ovarian carcinoma with thio-tepa.
Blinick G; Kabakow B; Wallach RC; Antopol W
Am J Obstet Gynecol; 1966 Oct; 96(3):425-9. PubMed ID: 4958483
[No Abstract] [Full Text] [Related]
7. [Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].
Neĭshtadt EL; Gnilevskaia ZU; Aĭnbinder NM
Vopr Onkol; 1975; 21(7):48-53. PubMed ID: 814712
[TBL] [Abstract][Full Text] [Related]
8. [Activity of enzymes of intermediate protein metabolism in thio-TEPA treatment of patients with ovarian cancer].
Lushnikova MV
Vopr Onkol; 1974 Oct; 20(7):96-7. PubMed ID: 4212533
[No Abstract] [Full Text] [Related]
9. [Endolymphatic polychemotherapy of cancer of the ovaries].
Pankov AK; Sidorenko IuS; Il'inskaia EG; Birbraer VM
Vopr Onkol; 1975; 21(4):55-7. PubMed ID: 812260
[No Abstract] [Full Text] [Related]
10. [A cytogenetic analysis of variants of a strain of rat ovary tumors resistant to 6-mercaptopurine and thio-TEPA].
Voitovitskii VK; Edygenova AK; Kabiev OK
Vopr Onkol; 1970 May; 16(5):87-92. PubMed ID: 4988932
[No Abstract] [Full Text] [Related]
11. [Role of chemotherapy in the treatment of malignant ovarian tumors].
Netschajewa ID
Zentralbl Gynakol; 1971 Nov; 93(48):1659-62. PubMed ID: 5004193
[No Abstract] [Full Text] [Related]
12. [Current status of chemotherapy of malignant tumors of the ovaries].
Nechaeva ID
Vopr Onkol; 1968; 14(6):108-22. PubMed ID: 4972640
[No Abstract] [Full Text] [Related]
13. [Functional state of the adrenal cortex in malignant tumors of the ovaries during thio-TEPA treatment].
Pankov AK; Smiller RR; Il'inskaia EG; Shurygina EA
Vopr Onkol; 1973; 19(4):31-5. PubMed ID: 4352994
[No Abstract] [Full Text] [Related]
14. [Mitotic activity changes in serous ovarian cystadenocarcinomas under treated with chemotherapy].
Irzhanov SI; Serov SF
Vopr Onkol; 1980; 26(10):60-3. PubMed ID: 6776688
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma.
Langer CJ; Nash S; Catalano R; Rosenblum NG; Hogan WM; Comis RL; O'Dwyer PJ
Gynecol Oncol; 1991 Dec; 43(3):242-6. PubMed ID: 1752494
[TBL] [Abstract][Full Text] [Related]
16. Combination antimetabolite and alkylating agent chemotherapy in advanced breast carcinoma.
Greenspan EM
N Y State J Med; 1968 Mar; 68(6):780-6. PubMed ID: 4967021
[No Abstract] [Full Text] [Related]
17. [The use of Thio-TEPA in patients with malignant diseases of the ovary].
Kuz'mina NA
Akush Ginekol (Mosk); 1966 Apr; 42(4):10-3. PubMed ID: 4965157
[No Abstract] [Full Text] [Related]
18. [Effect of Thio-TEPA on advanced ovarian cancer (author's transl)].
Luciani L; De Palo GM; Conti U; Mattavelli F; Di Re F
Tumori; 1973; 59(4):259-67. PubMed ID: 4357004
[No Abstract] [Full Text] [Related]
19. [A histochemical study of Shick-positive substances in cancerous tumors of the ovaries treated with thio-TEPA].
Kasab'ian SS; Zaĭchenko IuM
Akush Ginekol (Mosk); 1972 Jun; 48(6):71-3. PubMed ID: 4262647
[No Abstract] [Full Text] [Related]
20. [Mitotic activity in ovarian serous cystadenocarcinomas treated with thio-TEPA].
Irzhanov SI
Akush Ginekol (Mosk); 1979 Dec; (12):38-9. PubMed ID: 119443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
